Literature DB >> 2862460

Tamoxifen and contralateral breast cancer.

J Cuzick, M Baum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862460     DOI: 10.1016/s0140-6736(85)90338-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  30 in total

Review 1.  Contribution of randomised controlled trials to understanding and management of early breast cancer.

Authors:  M Baum; J Houghton
Journal:  BMJ       Date:  1999-08-28

Review 2.  Suitable trial designs and cohorts for preventive breast cancer agents.

Authors:  Kathrin Strasser-Weippl; Paul E Goss
Journal:  Nat Rev Clin Oncol       Date:  2013-10-08       Impact factor: 66.675

3.  The Sexual Activity Questionnaire: a measure of women's sexual functioning.

Authors:  K Thirlaway; L Fallowfield; J Cuzick
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

4.  The 4Ps of Breast Cancer Chemoprevention: Putting Proven Principles into Practice.

Authors:  V Craig Jordan
Journal:  Cancer Prev Res (Phila)       Date:  2017-02-28

5.  Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.

Authors:  Julia Prater; Fabio Valeri; Dimitri Korol; Sabine Rohrmann; Silvia Dehler
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-23       Impact factor: 4.553

6.  Lost in translation: can we afford to miss the trees for the forest?

Authors:  Stephen R Hammes; Carol A Lange
Journal:  Horm Cancer       Date:  2014-08       Impact factor: 3.869

Review 7.  Familiar drugs may prevent cancer.

Authors:  R A Sharma; A J Gescher; K J O'Byrne; W P Steward
Journal:  Postgrad Med J       Date:  2001-08       Impact factor: 2.401

Review 8.  Oncology.

Authors:  J S Malpas
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

Review 9.  The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.

Authors:  Ping Fan; Philipp Y Maximov; Ramona F Curpan; Balkees Abderrahman; V Craig Jordan
Journal:  Mol Cell Endocrinol       Date:  2015-06-05       Impact factor: 4.102

Review 10.  Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Authors:  V Craig Jordan; Joan Lewis-Wambi; Helen Kim; Heather Cunliffe; Eric Ariazi; Catherine G N Sharma; Heather A Shupp; Ramona Swaby
Journal:  Breast       Date:  2007-08-24       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.